TrialJournal for immunotherapy of cancer2022

Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study.

Manuel de la Torre-Aláez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.